{"id":"NCT03569475","sponsor":"Allergan","briefTitle":"Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder","officialTitle":"A Double-blind, Placebo- and Active-controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Pediatric Patients 7-17 Years With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-06","primaryCompletion":"2021-03-01","completion":"2021-03-01","firstPosted":"2018-06-26","resultsPosted":"2022-03-25","lastUpdate":"2022-03-25"},"enrollment":501,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Levomilnacipran ER","otherNames":[]},{"type":"DRUG","name":"Fluoxetine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Levomilnacipran ER 40-80 mg/day","type":"EXPERIMENTAL"},{"label":"Fluoxetine 20 mg/day","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran compared with placebo in pediatric outpatients (7-17 years) with major depressive disorder (MDD).","primaryOutcome":{"measure":"Change From Baseline in Children's Depression Rating Scale- Revised (CDRS-R)","timeFrame":"Baseline (Week 0) to Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-21.3,"sd":1.01},{"arm":"Levomilnacipran ER 40-80 mg/Day","deltaMin":-23,"sd":1.01},{"arm":"Fluoxetine 20 mg/Day","deltaMin":-23.1,"sd":1.01}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2215"},{"comp":"OG000 vs OG002","p":"0.1964"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":20},"locations":{"siteCount":51,"countries":["United States"]},"refs":{"pmids":["38700708"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":160},"commonTop":["Headache","Nausea","Decreased appetite","Insomnia","Tachycardia"]}}